ATE428931T1 - Verfahren zur durchführung von vollbluttests - Google Patents

Verfahren zur durchführung von vollbluttests

Info

Publication number
ATE428931T1
ATE428931T1 AT05759189T AT05759189T ATE428931T1 AT E428931 T1 ATE428931 T1 AT E428931T1 AT 05759189 T AT05759189 T AT 05759189T AT 05759189 T AT05759189 T AT 05759189T AT E428931 T1 ATE428931 T1 AT E428931T1
Authority
AT
Austria
Prior art keywords
whole blood
methods
disclosed
blood tests
performing whole
Prior art date
Application number
AT05759189T
Other languages
English (en)
Inventor
Mark Billadeau
Jeff Debad
Eli Glezer
Jonathan Leland
Charles Wijayawardhana
Original Assignee
Meso Scale Technologies Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meso Scale Technologies Llc filed Critical Meso Scale Technologies Llc
Application granted granted Critical
Publication of ATE428931T1 publication Critical patent/ATE428931T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • G01N33/521Single-layer analytical elements
    • G01N33/523Single-layer analytical elements the element being adapted for a specific analyte
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366Apparatus specially adapted for solid-phase testing
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/10Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/106664Blood serum or blood plasma standard or control
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/11Automated chemical analysis
    • Y10T436/117497Automated chemical analysis with a continuously flowing sample or carrier stream
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/25Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25125Digestion or removing interfering materials
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/25Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25375Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
AT05759189T 2004-06-03 2005-06-03 Verfahren zur durchführung von vollbluttests ATE428931T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57671004P 2004-06-03 2004-06-03
PCT/US2005/019498 WO2005121798A1 (en) 2004-06-03 2005-06-03 Methods and apparatuses for conducting assays

Publications (1)

Publication Number Publication Date
ATE428931T1 true ATE428931T1 (de) 2009-05-15

Family

ID=34982224

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05759189T ATE428931T1 (de) 2004-06-03 2005-06-03 Verfahren zur durchführung von vollbluttests

Country Status (6)

Country Link
US (3) US7776583B2 (de)
EP (1) EP1766400B1 (de)
AT (1) ATE428931T1 (de)
DE (1) DE602005013957D1 (de)
DK (1) DK1766400T3 (de)
WO (1) WO2005121798A1 (de)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2538038C (en) * 2003-09-11 2015-10-27 Theranos, Inc. Medical device for analyte monitoring and drug delivery
US7776583B2 (en) * 2004-06-03 2010-08-17 Meso Scale Technologies, Llc Methods and apparatuses for conducting assays
US8617907B2 (en) * 2004-06-07 2013-12-31 Alere Switzerland Gmbh Determining the presence or amount of a metal-labelled species
EP1836495A2 (de) * 2004-11-17 2007-09-26 BioVeris Corporation Elektrochemilumineszente untersuchung
GB0503836D0 (en) * 2005-02-24 2005-04-06 Axis Shield Asa Method
KR101931899B1 (ko) 2005-05-09 2018-12-21 테라노스, 인코포레이티드 현장진료 유체 시스템 및 그 용도
EP1888235A1 (de) * 2005-06-06 2008-02-20 Decision Biomarkers Incorporated Auf flüssigkeitsstrom über anordnungen basierende assays
US8741230B2 (en) 2006-03-24 2014-06-03 Theranos, Inc. Systems and methods of sample processing and fluid control in a fluidic system
US11287421B2 (en) 2006-03-24 2022-03-29 Labrador Diagnostics Llc Systems and methods of sample processing and fluid control in a fluidic system
US8007999B2 (en) 2006-05-10 2011-08-30 Theranos, Inc. Real-time detection of influenza virus
US20080113391A1 (en) * 2006-11-14 2008-05-15 Ian Gibbons Detection and quantification of analytes in bodily fluids
US8409509B2 (en) * 2007-04-12 2013-04-02 Regents Of The University Of Minnesota Systems and methods for analyzing a particulate
WO2009009630A1 (en) * 2007-07-11 2009-01-15 Clemson University Photoluminescent materials for multiphoton imaging
US8158430B1 (en) 2007-08-06 2012-04-17 Theranos, Inc. Systems and methods of fluidic sample processing
US20100260745A1 (en) * 2007-10-01 2010-10-14 University Of Southern California Methods of using and constructing nanosensor platforms
SE533515C2 (sv) * 2008-04-16 2010-10-12 Aamic Ab Analysförfarande för samtidig analys av flera analyter
US20100204062A1 (en) * 2008-11-07 2010-08-12 University Of Southern California Calibration methods for multiplexed sensor arrays
US20100135855A1 (en) * 2008-11-26 2010-06-03 Koninklijke Philips Electronics N.V. Method for depositing substances on a support
WO2010115143A1 (en) * 2009-04-03 2010-10-07 University Of Southern California Surface modification of nanosensor platforms to increase sensitivity and reproducibility
CA3081708C (en) 2009-10-19 2023-10-03 Theranos Ip Company, Llc Integrated health data capture and analysis system
EP2504466B1 (de) 2009-11-23 2019-11-20 Proxim Diagnostics Corporation Gesteuerte elektrochemische aktivierung von elektroden auf kohlenstoffbasis
KR101904497B1 (ko) 2010-01-29 2018-10-04 가부시키가이샤 엘에스아이 메디엔스 인간 sCD14―ST의 분석 방법
WO2011109379A1 (en) 2010-03-01 2011-09-09 Quanterix Corporation Methods and systems for extending dynamic range in assays for the detection of molecules or particles
US8236574B2 (en) 2010-03-01 2012-08-07 Quanterix Corporation Ultra-sensitive detection of molecules or particles using beads or other capture objects
US20110287959A1 (en) * 2010-05-20 2011-11-24 University Of Southern California Pan-antibody assays - principles, methods, and devices
EP2628013B1 (de) 2010-10-14 2019-06-12 The Johns Hopkins University Biomarker für gehirnverletzungen
US9731297B2 (en) 2011-01-06 2017-08-15 Meso Scale Technologies, Llc. Assay cartridges and methods of using the same
EP2527814A1 (de) * 2011-04-27 2012-11-28 Koninklijke Philips Electronics N.V. Sensorsystem mit austauschbarer Patrone und Lesegerät
JP2014518624A (ja) 2011-05-12 2014-08-07 ザ・ジョンズ・ホプキンス・ユニバーシティー ニューログラニン診断キットのためのアッセイ試薬
US9638663B2 (en) 2011-07-25 2017-05-02 Proxim Diagnostics Corporation Cartridge for diagnostic testing
RU2746407C1 (ru) 2012-02-23 2021-04-13 Стейдж Селл Терапеутикс Гмбх Хроматографическое выделение клеток и других сложных биологических материалов
US9213043B2 (en) 2012-05-15 2015-12-15 Wellstat Diagnostics, Llc Clinical diagnostic system including instrument and cartridge
US9081001B2 (en) 2012-05-15 2015-07-14 Wellstat Diagnostics, Llc Diagnostic systems and instruments
US9625465B2 (en) 2012-05-15 2017-04-18 Defined Diagnostics, Llc Clinical diagnostic systems
US20150025004A1 (en) * 2013-02-27 2015-01-22 Meso Scale Technologies, Llc Kidney function biomarkers
US9458488B2 (en) 2013-03-15 2016-10-04 Nanomix, Inc. Point of care sensor systems
EP3022322A4 (de) 2013-07-17 2017-05-17 The Johns Hopkins University Multiprotein-biomarkertest für den nachweis von hirnläsionen und ergebnis
BR112016024072B1 (pt) 2014-04-16 2021-02-09 Juno Therapeutics Gmbh método in vitro de estimular uma população de células
RU2763795C2 (ru) 2014-04-23 2022-01-11 Джуно Терапьютикс, Инк. Способы выделения, культивирования и генетической инженерии популяций клеток иммунной системы для адоптивной терапии
WO2016044697A1 (en) 2014-09-19 2016-03-24 The Johns Hopkins University Biomarkers of cognitive dysfunction
US11041865B2 (en) 2015-02-20 2021-06-22 The Johns Hopkins University Biomarkers of myocardial injury
JP7194020B2 (ja) 2015-10-22 2022-12-21 ジュノ セラピューティクス ゲーエムベーハー 細胞の培養方法ならびにそのためのキットおよび装置
US11248238B2 (en) 2015-10-22 2022-02-15 Juno Therapeutics Gmbh Methods, kits, agents and apparatuses for transduction
SG11201803330WA (en) 2015-10-22 2018-05-30 Juno Therapeutics Gmbh Methods for culturing cells and kits and apparatus for same
US10088494B2 (en) * 2016-01-25 2018-10-02 Perkinelmer Health Sciences, Inc. Method and system for microfluidic sample analysis
JP7339160B2 (ja) 2017-04-27 2023-09-05 ジュノ セラピューティクス ゲーエムベーハー オリゴマー粒子試薬およびその使用方法
US20190369119A1 (en) 2018-06-04 2019-12-05 Avon Products, Inc. Protein Biomarkers for Identifying and Treating Aging Skin and Skin Conditions
CN113474450A (zh) 2018-08-09 2021-10-01 朱诺治疗学股份有限公司 产生工程化细胞的方法以及所述工程化细胞的组合物
US20220082561A1 (en) * 2018-09-20 2022-03-17 Worcester Polytechnic Institute Methods to capture cells based on preferential adherence
EP3853615B1 (de) * 2018-09-20 2024-01-17 Siemens Healthcare Diagnostics, Inc. Verfahren und vorrichtung zur hiln-bestimmung mit einem tiefen anpassungsnetzwerk für sowohl serum- als auch plasmaproben
EP3874024A1 (de) 2018-10-31 2021-09-08 Juno Therapeutics GmbH Verfahren zur selektion und stimulation von zellen und vorrichtung dafür
AU2020232954B2 (en) 2019-03-01 2026-01-15 Meso Scale Technologies, Llc. Electrochemiluminescent labeled probes for use in immunoassay methods, methods using such and kits comprising same
WO2021222827A1 (en) 2020-05-01 2021-11-04 Meso Scale Technologies, Llc. Methods and kits for virus detection
WO2021236584A1 (en) 2020-05-19 2021-11-25 Meso Scale Technologies, Llc. Methods, compositions, and kits for nucleic acid detection
EP4222498A4 (de) 2020-09-29 2024-10-16 The Johns Hopkins University Integrierte proteomische biomarker zum nachweis von aggressivem prostatakrebs
US20240287572A1 (en) 2021-04-16 2024-08-29 Meso Scale Technologies, Llc. Methods, compositions, and kits for detecting hydrolase enzyme activity
US20220404360A1 (en) 2021-05-21 2022-12-22 Meso Scale Technologies, Llc. Assays for viral strain determination
JP2024526217A (ja) 2021-06-28 2024-07-17 メソ スケール テクノロジーズ エルエルシー アッセイシグナル増幅のための方法、組成物及びキット
WO2023245184A1 (en) 2022-06-17 2023-12-21 Meso Scale Technologies, Llc. Viral strain serology assays
US20240103002A1 (en) 2022-09-23 2024-03-28 Meso Scale Technologies, Llc. Orthopoxvirus serology assays
EP4638775A1 (de) 2022-12-20 2025-10-29 Meso Scale Technologies, LLC Testverfahren und kits
WO2025049305A1 (en) 2023-08-25 2025-03-06 Meso Scale Technologies, Llc. Viral strain serology assays

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE388694B (sv) * 1975-01-27 1976-10-11 Kabi Ab Sett att pavisa ett antigen exv i prov av kroppvetskor, med utnyttjande av till porost berarmaterial bundna eller adsorberande antikroppar
US4235601A (en) * 1979-01-12 1980-11-25 Thyroid Diagnostics, Inc. Test device and method for its use
US4366241A (en) * 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
US4442204A (en) * 1981-04-10 1984-04-10 Miles Laboratories, Inc. Homogeneous specific binding assay device and preformed complex method
US5208535A (en) * 1990-12-28 1993-05-04 Research Development Corporation Of Japan Mr position detecting device
US5460945A (en) * 1991-05-30 1995-10-24 Center For Blood Research, Inc. Device and method for analysis of blood components and identifying inhibitors and promoters of the inflammatory response
SE9401102D0 (sv) * 1994-03-31 1994-03-31 Pharmacia Biosensor Ab Assay method
EP0905514B1 (de) * 1997-09-27 2003-11-26 Horiba, Ltd. Gerät für die Zählung von Blutzellen und zur immunologischen Bestimmung unter Verwendung von Vollblut
US6475372B1 (en) * 2000-02-02 2002-11-05 Lifescan, Inc. Electrochemical methods and devices for use in the determination of hematocrit corrected analyte concentrations
US6383748B1 (en) * 1999-09-14 2002-05-07 Pamgene B.V. Analytical test device with substrate having oriented through going channels and improved methods and apparatus for using same
EP1583950B1 (de) * 2002-12-26 2017-04-05 Meso Scale Technologies, LLC. Testkassetten und verfahren zu ihrer verwendung
US7776583B2 (en) * 2004-06-03 2010-08-17 Meso Scale Technologies, Llc Methods and apparatuses for conducting assays

Also Published As

Publication number Publication date
DE602005013957D1 (de) 2009-05-28
US20120034645A1 (en) 2012-02-09
US20060019319A1 (en) 2006-01-26
US7776583B2 (en) 2010-08-17
EP1766400A1 (de) 2007-03-28
US8343526B2 (en) 2013-01-01
US8273566B2 (en) 2012-09-25
DK1766400T3 (da) 2009-07-20
US20100267063A1 (en) 2010-10-21
WO2005121798A1 (en) 2005-12-22
EP1766400B1 (de) 2009-04-15

Similar Documents

Publication Publication Date Title
ATE428931T1 (de) Verfahren zur durchführung von vollbluttests
DE502004008216D1 (de) Vorrichtung und verfahren zur simultanen durchführung von blutgruppenbestimmung, serumgegenprobe und antikörpersuch-test
SE0303249D0 (sv) Hematocrit and analyte concentration determination
WO2004011607A3 (en) Reagent and method for determination of a substance using an immunoaggregator
ATE554168T1 (de) Integriertes mikrofluidisches bauteil zum aufreinigen von analytmolekülen sowie verfahren zum aufreinigen
CY1117282T1 (el) Διαταξη και μεθοδος ανιχνευσεως προσδιοριζομενων ουσιων
ATE278771T1 (de) Vorrichtung und verfahren zur analyse flüssiger proben
ATE553216T1 (de) Sonden, bibliotheken und kits zur analyse von nukleinsäuregemischen und verfahren zu deren konstruktion
ATE541054T1 (de) Bio-barcode erkennung für zielmoleküle
ATE431854T1 (de) Auf bio-barcodes beruhender nachweis von zielanalyten
ATE428929T1 (de) Reagens, ausstattung und verfahren zur probenanalyse
ATE510931T1 (de) Materialien und verfahren zur erfassung von pathogenen und entfernung von aurin- tricarbonsäure aus einer probe
MX369610B (es) Metodos, dispositivos y sistemas para analisis de muestras.
ATE408829T1 (de) Verfahren und assaykits zum nachweis mononuklearer zellphänotypen
DE502005004800D1 (de) Vorrichtung und verfahren zum nachweis von analyten durch sichtbarmachung und separation von agglutination
WO2002042500A3 (en) Apparatus and method for electrophoretic microspot concentration
WO2005024384A3 (en) Devices and methods for separating phospholipids from biological samples
DE602005015299D1 (de) Verfahren, chip, vorrichtung und integriertes system zum nachweis biologischer partikel
ATE421095T1 (de) Porosität und biologische aktivität beibehaltende haftmembranen in einer assay-einrichtung zur messung von serum cholesterin in assoziation mit hochdichten lipoproteinen
ATE378591T1 (de) Verfahren und vorrichtung zur vorhersage von kardiovaskulären ereignissen
ATE416384T1 (de) Verfahren und kit zum quantitativen und/oder qualitativen nachweis von komponenten in einer probe
ATE360213T1 (de) Bestimung und quantifizierung von erythrocytenpopulationen in proben
WO2006051548A3 (en) Blood type method system and device
ATE405592T1 (de) Verfahren zur bildung eines protein- mikroarraysystems
ATE444491T1 (de) Verfahren zur bestimmung von kardiovaskulären risikofaktoren

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties